In the matter of Recce Pharmaceuticals Ltd [2021] NSWSC 1316
[2021] NSWSC 1316
At a glance
Source factsCourt
Supreme Court of NSW
Decision date
2021-10-12
Before
Black J
Source
Original judgment source is linked above.
Judgment (6 paragraphs)
Solicitors: Automic Legal Pty Ltd (Plaintiff) File Number(s): 2021/288717
Background
- By Originating Process filed on 11 October 2021, the Plaintiff, Recce Pharmaceuticals Ltd ("Recce") applies for orders validating any sales or offers of sale of certain shares without disclosure under s 707 of the Corporations Act 2001 (Cth) and associated orders under s 1322(4) of the Act, in circumstances that it issued 10,000 ordinary fully paid shares on 2 September 2021 without issuing a cleansing notice under s 708A of the Corporations Act. It also seeks associated orders under 1322 of the Act, directed, in effect, to validating the issue and preserving the ability of shareholders to rely on exemptions from disclosure in respect of subsequent sales of their shares. The issues arising in this case are of the kind that have arisen in several earlier cases, including Re Golden Gate Petroleum Ltd (2010) 77 ACSR 17; [2010] FCA 40, Re Kollakorn Corporation Ltd [2020] NSWSC 1549 and Re Airtasker Ltd [2021] NSWSC 629.